New Wave of Imaging AI Tools Cleared

The recent Brainomix clearance allows for the assessment of ischemic core volume on non-contrast CT scans, a significant development as it provides advanced stroke insights without requiring more complex CT perfusion or MRI scans. This technology aims to improve decision-making for patient treatment and transfer, and in real-world studies, its use was associated with a more than 50% increase in mechanical thrombectomy rates. Qure.ai's six new 510(k) clearances for its qXR-Detect chest X-ray software bring its total to 26 FDA-cleared indications. Notably, the clearance includes a Predetermined Change Control Plan (PCCP), making it the only chest X-ray computer-assisted detection device with this plan, which allows for algorithm updates without needing separate regulatory submissions. This provides health systems with access to the most current version of the algorithm as it evolves. These approvals are part of a massive influx of AI into medical imaging, with radiology-specific tools accounting for nearly 80% of all AI devices authorized by the FDA. As of late 2025, the number of AI/ML algorithms cleared for radiology surpassed 1,000, a dramatic increase from the roughly 500 devices on the list in early 2023. This technological push coincides with major site-of-care shifts driven by reimbursement policies from both CMS and private payors like UnitedHealth. Site-neutral payment policies, which reduce reimbursement for services performed at hospital outpatient departments to levels closer to independent imaging centers, are accelerating the migration of imaging volume to more cost-effective outpatient settings. In response, health systems are aggressively expanding their freestanding imaging footprints through de novo development, acquisitions, and joint ventures with independent diagnostic testing facilities (IDTFs). This strategy allows hospitals to retain imaging volume that is shifting away from the main campus while capitalizing on the more efficient operational model of outpatient centers. The adoption of AI is also a direct response to a critical and growing radiologist shortage, with demand for imaging expected to outpace the supply of radiologists for decades. Facing rising imaging volumes and staff burnout, radiology departments are turning to AI to automate tasks, improve efficiency, and triage urgent cases to manage unsustainable workloads. The outpatient imaging market itself is undergoing significant consolidation, with large operators like RadNet and Akumin Inc. actively acquiring smaller players and partnering with health systems. This trend, often fueled by private equity investment, is creating larger, more scaled networks that are changing the competitive landscape for mobile imaging providers.